Veeva RTSM enabled a small biotechnology company to repeatedly pivot their Phase 1 dose-escalation and expansion study with speed, quality, and precision, transitioning seamlessly from paper-based processes—including the initial protocol and four amendments—to full RTSM functionality amid scope expansion. Facing challenges with existing study data on paper and small initial scopes, Veeva implemented RTSM on the live study effortlessly. It unified data management, automated adaptations to evolving protocol requirements, eliminated manual errors, accelerated study progress, and ensured compliance for efficient, high-quality execution.

Join for free to read